Clinical trials
Alzheimer Disease or Associated Disorder clinical trials
Below are recruiting alzheimer disease or associated disorder clinical trials, each written for real people, not researchers. We’re tracking 1,816 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05124392Recruiting
Study biomarkers in people at risk for prion disease
This study checks blood and spinal fluid “biomarkers” (measurable signs) and uses memory/thinking tests to learn who may be developing prion disease. It may help researchers better predict risk earlier in families affected by prion disease.
Charlestown, MassachusettsAges 18–85 - NCT05414708Recruiting
Art therapy for veterans with PTSD symptoms
This study tests whether art therapy can improve emotional well-being in military members who have significant PTSD symptoms. You would answer questionnaires and likely take part in art-making sessions as part of the treatment being studied.
Bethesda, MarylandAges 18–64 - NCT05515367RecruitingPhase 4
Real-world safety study of desidustat for kidney anemia
This study tracks the real-world safety of desidustat in adults with anemia caused by chronic kidney disease (CKD). It’s meant to see whether the medicine is safe when used in everyday care, not just in tightly controlled settings.
Sheikhpura, BiharAges 18–85 - NCT05516719Recruiting
Study tracking I2BS in Parkinson’s over time
This study follows people with Parkinson’s to see how “I2BS” changes over time using special brain scans and other tests. It may help researchers better understand Parkinson’s and improve how it’s measured in future trials.
Exeter, DevonAges 25 years+ - NCT05641623RecruitingPhase 2
Study drug for depression that didn’t improve on common antidepressants
This Phase 2 trial tests OSU6162 added to an SSRI or SNRI in people whose major depression did not improve enough after trying specific antidepressants for at least 6 weeks. It may help reduce depression symptoms when standard treatments haven’t worked well.
Lund, Skåne CountyAges 25–65 - NCT06025149Recruiting
Study of a New Biological Heart Valve 'UniLine'
This study tests a new biological heart valve called 'UniLine' for people who need to replace their mitral valve (the valve between the left heart chambers) or aortic valve (the main valve sending blood to the body) for the first time. If you qualify, you would have planned surgery (not an emergency) and need to be free of certain other serious health conditions.
Kemerovo, Kemerovo OblastAges 18–80 - NCT06045897Recruiting
EEG brain test for young people at risk of psychosis
This study uses a short EEG recording to look at brain activity patterns in young people with early signs of mental health conditions, including those at risk for psychosis, first episode psychosis, depression, or autism. It aims to find brain markers that could help identify people who might benefit from early treatment.
ParisAges 15–30 - NCT06248229RecruitingPhase 4
Testing Dyanavel XR for fatigue in adults with ADHD
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
Rochester Hills, MichiganAges 18–65 - NCT07694258Recruiting
Testing a helmet for brain stimulation in consciousness disorders
This study tests a special helmet that uses ultrasound to stimulate the brain in people with disorders of consciousness caused by brain injury. It aims to see if the treatment is safe and possible to do.
Toronto, OntarioAges Any age - NCT06523608Recruiting
Predicting liver problems in advanced chronic liver disease
This study looks at people with advanced chronic liver disease to find ways to predict when they might get worse or develop liver cancer. Researchers hope to use this information to prevent complications and improve care.
Münster, North Rhine-WestphaliaAges 18 years+ - NCT06843044RecruitingPhase 4
Testing Ranquilon for anxiety from stress or exhaustion
This study tests a new medication called Ranquilon to see how well it treats anxiety in people with neurasthenia or adjustment disorders. Participants will take the study drug for about 4 weeks, and doctors will check their anxiety and fatigue levels.
Engel'sAges 18–70 - NCT06854367Recruiting
Comparing fast vs. standard brain stimulation for depression in older adults
This study tests if a faster form of brain stimulation (accelerated theta burst stimulation) works as well as the standard version for treating depression in adults 60 and older. It may help those who haven't gotten relief from antidepressant medications.
Toronto, OntarioAges 60 years+ - NCT06927739RecruitingPhase 2
Orticumab for heart artery inflammation after a heart attack
This trial tests a drug called orticumab to see if it can reduce inflammation in the arteries of the heart after a heart attack. It may help prevent future heart problems.
Los Angeles, CaliforniaAges 18 years+ - NCT06930885RecruitingPhase 3
Polypill and colchicine for heart and artery risk
This trial tests a combination pill (polypill) and a medicine called colchicine to see if they can lower the risk of future heart attacks, strokes, or other artery problems. It is for people who already have a history of heart or blood vessel disease.
Maceió, AlabamaAges 45 years+ - NCT06953505Recruiting
At-home ammonia monitoring for inherited metabolic disorders
This trial tests a device for measuring ammonia levels at home in people with rare metabolic conditions that cause high ammonia. It aims to make monitoring easier and more convenient for patients.
Portland, OregonAges 12 years+ - NCT07098169Recruiting
Testing a program to improve self-awareness for schizophrenia
This trial tests a program called iTEST that helps people with schizophrenia or schizoaffective disorder improve how accurately they understand their own thoughts. The program combines device use with feedback from a clinician or loved one to support better self-awareness.
San Diego, CaliforniaAges 18–65 - NCT07118839RecruitingPhase 2/Phase 3
MDMA therapy for veterans with PTSD and alcohol use
This study tests whether MDMA-assisted therapy can help veterans who have both PTSD and alcohol use disorder. If you have tried a standard therapy before and want to reduce or stop drinking, this treatment may offer a new option.
West Haven, ConnecticutAges 18 years+ - NCT07198594Recruiting
Fast brain stimulation for hard-to-treat OCD
This study tests a fast-acting brain stimulation method (accelerated rTMS) for people whose obsessive-compulsive disorder has not improved enough with standard treatments. It aims to help those who still have moderate to severe symptoms despite trying multiple medications.
Shanghai, Shanghai MunicipalityAges 18–60 - NCT07318155RecruitingPhase 2
Study of SRSD107 for chronic heart or leg artery disease
This study tests a new medicine called SRSD107 for people with long-term blockages in heart or leg arteries. It aims to see if the drug can help prevent clots safely.
BeijingAges 18–75 - NCT07318480Recruiting
tDCS for Cocaine Use Disorder
This study tests whether a non-invasive brain stimulation method called tDCS can help reduce cocaine use. You would receive several sessions of mild electrical current applied to your scalp, which may help control cravings and improve your ability to stay abstinent.
New York, New YorkAges 18–60 - NCT07329257Recruiting
Project PENGUIN: Study of rare brain development disorders
This study looks at rare and ultra-rare conditions that affect brain development. It aims to learn more about what causes these conditions. You may join if you or your child have a diagnosed or suspected neurogenetic disorder.
Columbia, MissouriAges Up to 99 years - NCT00001979Recruiting
Understanding Immune System Kidney Disease
This research study looks at kidney diseases caused by the immune system—conditions where your body's defense system mistakenly attacks the kidneys. Researchers will study your medical history, blood, and urine to better understand these diseases and potentially improve treatment.
Bethesda, MarylandAges 10–99 - NCT03258567RecruitingPhase 2
Nivolumab for EBV-related lymphomas and abnormal immune illnesses
This trial tests nivolumab (an immune therapy) for people with EBV-positive lymphoma or EBV-driven immune/lymph conditions. It may help shrink tumors or control the disease when standard treatments have not worked or are not suitable.
Bethesda, MarylandAges 12 years+ - NCT07677046Enrolling by invitation
Combination therapy for complex dissociative disorder
This trial studies a therapy called Deep Brain Reorienting (DBR) combined with group sessions for people with complex dissociative disorder, such as dissociative identity disorder (DID) or other specified dissociative disorder (OSDD). The goal is to help process trauma in a safe and supportive setting.
Oslo, OsloAges 18 years+
Hear when a new Alzheimer Disease or Associated Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for alzheimer disease or associated disorder?
- Yes. Clin2 currently lists 1,816 recruiting alzheimer disease or associated disorder studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a alzheimer disease or associated disorder trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a alzheimer disease or associated disorder trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.